Exercise, PNE and Cognitive Training in Individuals With Chronic Low Back Pain

November 8, 2023 updated by: Ellen Hirose Pereira Nery, Aveiro University

Pain Neuroscience Education, Exercise, and Cognitive Training in Individuals With Idiopathic Chronic Low Back Pain: a Three-arm Randomized Trial

This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).

Study Overview

Detailed Description

This study aims of to investigate whether combining cognitive training to exercise and Pain Neuroscience Education (PNE) will contribute to reduction of pain and associated symptoms (i.e., catastrophizing, fear of movement, disability) in individuals with low back pain (LBP).

It will have three arms of which will receive exercise, PNE and/or cognitive training for 8 weeks (Group I - exercise and PNE; Group II - exercise, PNE and cognitive training; Group III - cognitive training).

Participants will be assessed for pain characteristics, psychological, and cognitive aspects at baseline, post-intervention and at 3 months follow-up.

Study Type

Interventional

Enrollment (Estimated)

83

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Anabela Silva
  • Phone Number: +351234370200
  • Email: asilva@ua.pt

Study Locations

      • Aveiro, Portugal
        • Recruiting
        • University of Aveiro
        • Contact:
          • Ellen Nery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • have chronic idiopathic LBP
  • report pain intensity of at least 2 out of 10 on the Numeric Pain Rating Scale
  • 18 to 64 years old
  • Be able to read, write and speak Portuguese
  • Asses to personal computer and internet for those receiving cognitive training

Exclusion Criteria:

  • individuals receiving any chronic treatment for their pain
  • symptoms of peripheral nervous system pathology (e.g., motor weakness and sensory disturbance);
  • a diagnosis of an ongoing neurological disease with peripheral or central nervous system involvement or relevant sequela;
  • having a diagnosis of ongoing psychiatric disease
  • having relevant cognitive impairment as assessed by Montreal Cognitive Assessment (MoCA).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention 1
Participants will receive exercise, PNE and online cognitive training sessions.
Cognitive training combined with the recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).
Active Comparator: Intervention 2
Participants will receive exercise and pain neuroscience education (PNE).
Recommended non-pharmacological intervention (Exercise and Pain Neuroscience Education).
Active Comparator: Intervention 3
Participants will receive online cognitive training sessions.
Online sessions of cognitive training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale Numeric Pain Rating Scale
Time Frame: baseline
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable".
baseline
Numeric Pain Rating Scale Numeric Pain Rating Scale
Time Frame: post-intervention - 8 weeks
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable".
post-intervention - 8 weeks
Numeric Pain Rating Scale Numeric Pain Rating Scale
Time Frame: 3 months follow-up
Measured with a 11-point scale ranging from 0 meaning "no pain" to 10 meaning "the worst pain imaginable".
3 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive Function
Time Frame: baseline
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance.
baseline
Cognitive Function
Time Frame: post-intervention - 8 weeks
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance.
post-intervention - 8 weeks
Cognitive Function
Time Frame: 3 months follow-up.
Cognitive function will be assessed using the Brain on Track® (BoT), a self-administered computerized test that evaluates different cognitive domains. Each test has a virtually unlimited range score and considers the maximum number of correct answers that a person gives in a fixed period of time and higher scores represent higher cognitive performance.
3 months follow-up.
Roland Morris disability questionnaire
Time Frame: baseline
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability.
baseline
Roland Morris disability questionnaire
Time Frame: post-intervention - 8 weeks
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability.
post-intervention - 8 weeks
Roland Morris disability questionnaire
Time Frame: 3 months follow-up
The Roland Morris assesses disability caused by LBP. It has 24 statements, and the individual must tick those that relate to him that day. The total score ranges from "0" meaning no disability to "24" meaning maximum disability.
3 months follow-up
Central sensitization Inventory
Time Frame: baseline
The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points.
baseline
Central sensitization Inventory
Time Frame: post-intervention - 8 weeks
The central sensitization inventory (CSI) assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points.
post-intervention - 8 weeks
Central sensitization Inventory
Time Frame: 3 months follow-up
The central sensitization inventory (CSI)assesses symptoms of central sensitization. The total score ranges from 0 to 100 points and to identify central sensitization in individuals, the recommended cut-off score is 40 points.
3 months follow-up
Hospital Anxiety and Depression Scale (HADS)
Time Frame: baseline
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression.
baseline
Hospital Anxiety and Depression Scale (HADS)
Time Frame: post-intervention - 8 weeks
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression.
post-intervention - 8 weeks
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 3 months follow-up.
HADS evaluates symptoms of anxiety and depression. The total scores range from 0 to 21 points with a 4-point Likert scale rating between "most of the times" and "not at all" with higher scores indicating higher levels of anxiety and depression.
3 months follow-up.
TAMPA Scale of Kinesiophobia
Time Frame: baseline
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement.
baseline
TAMPA Scale of Kinesiophobia
Time Frame: post-intervention - 8 weeks
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement.
post-intervention - 8 weeks
TAMPA Scale of Kinesiophobia
Time Frame: 3 months follow-up.
The Tampa scale measures the fear of movement related to chronic LBP. The short version has 13 items in a 4-point Likert scale rating between "strongly disagree" and "strongly agree". The total scores range from 0 to 52 points with higher levels indicating higher fear of movement.
3 months follow-up.
Pain Catastrophizing Scale
Time Frame: Baseline
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing.
Baseline
Pain Catastrophizing Scale
Time Frame: post-intervention - 8 weeks
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing.
post-intervention - 8 weeks
Pain Catastrophizing Scale
Time Frame: 3 months follow-up.
The Pain Catastrophizing Scale (PCS) assess catastrophic thinking related to pain. It has 13 statements on a 5-point scale ranging from 0 meaning "not at all" and 4 meaning "all the time". The total score ranges from 0 to 52 with higher scores indicating higher levels of catastrophizing.
3 months follow-up.
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Time Frame: baseline
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep.
baseline
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Time Frame: post-intervention - 8 weeks
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep.
post-intervention - 8 weeks
Basic Scale on Insomnia Complaints and Quality of Sleep (BaSIQs)
Time Frame: 3 months follow-up.
The scale assess the difficulties with sleep onset and maintenance and the quality and depth of sleep during the last month and considering a normal week. Total score ranges from 0 to 28 points and higher scores are associated with poor quality of sleep.
3 months follow-up.
Two-point discrimination
Time Frame: baseline
Two-point discrimination is used to assess cortical reorganization.
baseline
Two-point discrimination
Time Frame: post-intervention - 8 weeks
Two-point discrimination is used to assess cortical reorganization.
post-intervention - 8 weeks
Two-point discrimination
Time Frame: 3 months follow-up
Two-point discrimination is used to assess cortical reorganization.
3 months follow-up
Patient's Global Impression of Change (PGIC)
Time Frame: post-intervention - 8 weeks
PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition.
post-intervention - 8 weeks
Patient's Global Impression of Change (PGIC)
Time Frame: 3 months follow-up.
PGIC evaluates the perception of improvement associated with the intervention. Participants are instructed to select on a scale from 1 ("No change or condition worsened") to 7 ("Much better, and with a considerable improvement that made all the difference") the statement that best reflected the impact of the intervention on their condition.
3 months follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Anabela Silva, PhD, School of Health Sciences, University of Aveiro

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2023

Primary Completion (Estimated)

February 10, 2024

Study Completion (Estimated)

March 1, 2024

Study Registration Dates

First Submitted

February 23, 2023

First Submitted That Met QC Criteria

March 8, 2023

First Posted (Actual)

March 21, 2023

Study Record Updates

Last Update Posted (Estimated)

November 9, 2023

Last Update Submitted That Met QC Criteria

November 8, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RCTCognitiveTraining

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe